Glass House: Glass Problems
Glass House Brands has fallen victim to a couple of negative trends: SPACs and cannabis in general. While these trends are hurting the stock, the biggest problem is a focus on consolidating the highly competitive California cannabis market. My investment thesis is Neutral on the stock due to this focus of repeating the issues of the Canadian cannabis market.
Read the full article on Seeking Alpha.
Disclosure: No position mentioned. Please review the disclaimer page for more details.
Update - Nov. 18
Some very negative comments on California overproduction from the WM Tech. (MAPS) Q3'21 earnings call continue to confirm that Glass House bought into the California cultivation market at exactly the wrong time. Investors must avoid this cannabis stock for now.
-While licenses continue to be issued across our end markets, licensed density is not where it needs to be in the pace of license issuance remained sluggish, which is contributing to a thriving illicit market. And further, there has been a lot written in the press about how producers are dealing with the current supply glut, by in some cases diverting products to unlicensed market channels at significant price discounts, which is only further fueling the consumer demand shift.